Instil Bio, INC 8-K filings

NASDAQ

16 Jan 2024

TIL

8-K: Instil Bio Announces Restructuring Plan, Closes UK Operations, and Shifts Focus to US-Based Development

Instil Bio is closing its UK manufacturing and clinical trial operations, reducing its workforce by approximately 61%, and shifting its focus to a US-based development strategy.